Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy.

Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marbán E, Hare JM.

Circulation. 2001 Nov 13;104(20):2407-11.

2.
3.

[Therapy of dilated cardiomyopathy with recombinant human growth hormone].

Osterziel KJ, Markus U, Willenbrock R, Strohm O, Dietz R.

Z Kardiol. 1997 Oct;86(10):803-11. Review. German.

PMID:
9454447
4.

Oxipurinol: alloxanthine, Oxyprim, oxypurinol.

[No authors listed]

Drugs R D. 2004;5(3):171-5. Review.

PMID:
15139781
5.

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.

George J, Struthers AD.

Vasc Health Risk Manag. 2009;5(1):265-72. Epub 2009 Apr 8. Review.

6.

Glucagon-like peptide-1 and myocardial protection: more than glycemic control.

Fields AV, Patterson B, Karnik AA, Shannon RP.

Clin Cardiol. 2009 May;32(5):236-43. doi: 10.1002/clc.20456. Review.

7.

Allopurinol, xanthine oxidase, and cardiac ischemia.

Lee BE, Toledo AH, Anaya-Prado R, Roach RR, Toledo-Pereyra LH.

J Investig Med. 2009 Dec;57(8):902-9. doi: 10.2310/JIM.0b013e3181bca50c. Review.

PMID:
19794315
8.

Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis.

Higgins P, Dawson J, Lees KR, McArthur K, Quinn TJ, Walters MR.

Cardiovasc Ther. 2012 Aug;30(4):217-26. doi: 10.1111/j.1755-5922.2011.00277.x. Epub 2011 Jun 12. Review.

PMID:
22099531
9.

Systolic heart failure and the cardiomyopathy of overload.

Messineo FC.

Hosp Pract (Off Ed). 1990 Sep 30;25(9A):66-70, 77-9, 82-4. Review. No abstract available.

PMID:
2119382
10.

Energy metabolism of the heart: from basic concepts to clinical applications.

Taegtmeyer H.

Curr Probl Cardiol. 1994 Feb;19(2):59-113. Review. No abstract available.

PMID:
8174388
11.

Heart failure, oxidative stress and allopurinol.

Biagi P, Abate L.

Monaldi Arch Chest Dis. 2005 Mar;64(1):33-7. Review.

PMID:
16128162
12.

Xanthine Oxidase Pathway and Muscle Damage. Insights from McArdle Disease.

Pareja-Galeano H, Santos-Lozano A, Morán M, Sanchis-Gomar F, Alis R, Santalla A, San Juan AF, Díez-Bermejo J, Martín MA, Arenas J, Lucia A.

Curr Pharm Des. 2016;22(18):2657-63. Review.

PMID:
26861723
13.

Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic cardiomyopathy.

Møller S, Henriksen JH.

Scand J Gastroenterol. 2001 Aug;36(8):785-94. Review. No abstract available.

PMID:
11495071
14.

[Competitive enzyme mechanisms in the therapy of hemoblastosis using antimetabolites].

Wilmanns W.

Verh Dtsch Ges Inn Med. 1968;74:822-30. Review. German. No abstract available.

PMID:
4977259

Supplemental Content

Support Center